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Tobacco Cessation and Cancer Patients – Perspective of an ENT Resident
Lauren Klute
University of Nebraska Medical Center, Department of Otolaryngology – Head and Neck Surgery
Between 2009 and 2013, 343,000 people 
died per year from a cancer related to tobacco 
use. Three in ten deaths related to cancer 
were secondary to cigarette smoking.1 Head 
and neck cancer (HNSCC), in particular, 
is a devastating disease and the sixth most 
common form of cancer worldwide. Studies 
have shown that the risk of HNSCC in 
smokers is 10 times higher than that of 
never-smokers, and 70-80% of new HNSCC 
diagnoses are associated with tobacco 
and alcohol use.1,2 HNSCC is particularly 
debilitating as patients can be left unable 
to communicate, tube fed, and with various 
cosmetic disfigurements. Additionally, many 
of these patients are unable to return to work 
and must rely on state-sponsored income.
Research shows that continuing to smoke 
following a cancer diagnosis can result in 
reduced treatment effectiveness (diminished 
radiation efficacy), worsens prognosis, 
and contributes to an increase in cancer 
recurrence. Smoking can also result in higher 
complication rates, poorer surgical outcomes, 
and second primary cancers.3 Chen et al. 
found that patients who continued smoking 
throughout radiation treatment demonstrated 
inferior five-year overall survival (23% vs. 
55%), loco-regional control (58% vs. 69%), 
and disease-free survival (42% vs. 65%) 
compared to non-smokers.4 Post-operative 
patients were six times more likely to have a 
complication including vascular, pulmonary, 
renal, anemia, ethanol withdrawal, wound 
complications, urinary tract infections, and 
delirium, in addition to a longer length of 
stay.5 Frequently HNSCC patients require free 
flap tissue transfer in order to close ablative 
defects and improve function.
Tobacco and nicotine impair wound healing 
and end-organ O2 delivery. This can lead to 
luminal thrombosis and flap failure.5 Many of 
those patients require another flap or are faced 
with long-term wound management.
After a life-changing diagnosis, many patients 
are highly motivated to quit smoking. Most 
cancer patients will make an attempt within 
six months of their diagnosis. Participating 
in a tobacco cessation program can increase 
the likelihood of a successful quit attempt and 
can result in sustained high abstinence rates.6 
Studies have shown that the combination of 
behavioral and pharmacological treatments 
for nicotine dependence has led to significant 
progress in the abstinence attempts.7 Thus, 
several hospitals have attempted to develop 
smoking cessation programs. One such 
program consisted of an initial in-person 
medical consultation, followed by 6-8 in-
person or telephone counseling sessions, and 
10-12 weeks of pharmacotherapy.6 Several 
programs have integrated tobacco cessation 
specialists into the office work-flow.
Hospitalization offers a unique opportunity 
to initiate cessation and can provide access 
to interventions. From a systematic review of 
tobacco cessation interventions for hospital 
smokers, the most promising strategies 
were training nurses to deliver bedside 
interventions and facilitating the use of 
nicotine replacement therapy after discharge 
by providing a free supply.8,9 In the initial 
study, nurses were educated on counseling 
for in-patients and provided toolkits for 
patients to assists in smoking cessation. This 
program also enrolled patients in follow-up 
phone calls by hospital volunteers at 2, 7, 
14, 21, and 30 days. Following this program, 
there was significant improvement in six 
month quit rates.10 The Medical University 
of South Carolina instituted a policy that all 
hospitalized patients who self-report using 
tobacco be referred to tobacco cessation 
services. This consisted of a bedside consult 
and phone follow-up at 3, 14, and 30 days. 
Receiving this consultation while hospitalized 
increased the use of medications and 
abstinence from smoking after discharge.11 
Several hospitals have implemented programs 
for referrals to state quit lines. While referral 
to the state quit line can also assist with 
follow-up and counseling, this referral has not 
necessarily been shown to improve abstinence 
rates.8
The University of Nebraska Medical Center 
(UNMC) strives to provide comprehensive 
care of patients and integrating a smoking 
cessation program into the various cancer 
specialties will improve patient outcomes and 
survival. Leading the way in tobacco cessation 
at UNMC are Jill Selzle, PA-C, Susie Moore, 
APRN, and Tom Klingemann, PharmD. 
Ms. Selzle and Ms. Moore currently run the 
Tobacco Dependence Clinic through the 
Office of Thoracic Surgery. They are trained 
certified tobacco treatment specialists. They 
utilize personal treatment plans, implement 
behavioral techniques, and offer medications. 
“Their goal is to help patients understand 
the science, withdrawal, symptoms, and 
treatments.”12 Dr. Klingemann, provides 
education encompassing the psychological 
and physical triggers in routines. His goal is to 
merge available and effective therapies.12
Boundaries to instituting cessation programs 
do exist. As previously discussed, the most 
successful quit attempts rely on behavioral 
intervention in addition to medication therapy. 
Currently, UNMC has limited staff that are 
trained in tobacco cessation counseling and 
providers who are well-versed in medications 
and side effects. Smoking cessation 
interventions can also be difficult to integrate 
into current out-patient workflow.
Starting the discussion about smoking 
cessation can require a time investiture from 
the provider and associated staff. Proximity 
to services can also be a barrier, as many 
patients hail from Western Nebraska or the 
surrounding states. Finally, there is also a vast 
variability in the coverage from insurance 
companies. While the federal law requires 
many plans to cover tobacco cessation 
services, there is significant variability in the 
coverage terms. Many require copays or prior 
authorization for treatments and medications. 
Some policies limit treatment duration to 
90 days and limit the number of total quit 
attempts.13 Despite these boundaries, the 
patients would benefit from further cessation 
programs provided by UNMC. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.005
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